Research Article

Blood Biochemical and Hematological Study after Subacute Intravenous Injection of Gold and Silver Nanoparticles and Coadministered Gold and Silver Nanoparticles of Similar Sizes

Table 5

Hematological values of male rats in after 4 weeks of recovery (n=3).

Dose (µg/kg)G1G2G3G4G5G6G7
ControlSilver 10Silver 100Gold 10Gold 100Mix 10Mix 100

WBC1 (K/μL)5.90±1.175.11±0.427.38±0.295.48±1.377.07±0.726.55±0.947.95±1.05

NE2 (K/μL)0.93±0.150.95±0.051.44±0.091.21±0.240.82±0.090.99±0.200.79±0.13

LY3 (K/μL)4.84±1.173.98±0.425.77±0.504.13±1.145.96±0.585.27±0.646.89±1.07

MO4 (K/μL)0.05±0.010.08±0.020.08±0.030.03±0.010.17±0.060.17±0.080.14±0.04

EO5 (K/μL)0.07±0.010.10±0.030.08±0.010.09±0.010.11±0.020.10±0.020.12±0.01

BA6 (K/μL)0.00±0.000.00±0.000.00±0.000.003±0.0030.00±0.000.003±0.0030.003±0.003

NE7 (%)16.87±3.9618.90±2.3519.70±2.1022.67±2.3811.63±0.8714.83±0.9010.20±2.31

LY8 (%)80.97±3.7077.63±1.6477.90±2.5074.73±2.5584.33±1.0581.00±1.8586.20±2.95

MO9 (%)0.90±0.151.53±0.351.20±0.470.67±0.072.23±0.722.33±0.831.73±0.52

EO10 (%)1.17±0.071.80±0.401.10±0.151.80±0.261.63±0.271.53±0.121.60±0.17

BA11 (%)0.00±0.000.03±0.030.03±0.030.03±0.030.00±0.000.07±0.030.03±0.03

RBC12 (M/μL)8.29±0.108.16±0.258.05±0.298.40±0.238.25±0.268.11±0.288.54±0.06

Hb13 (g/dL)15.23±0.3315.30±0.5315.30±0.1514.93±0.2015.70±0.4615.40±0.2516.13±0.24

HCT14 (%)44.50±0.9245.10±1.2545.70±0.3645.23±0.6746.57±1.4747.27±0.8848.30±1.08

MCV15 (fL)53.67±0.6255.20±0.7056.90±2.4453.97±1.9456.43±0.6858.50±3.1356.57±1.17

MCH16 (pg)18.37±0.2418.73±0.2619.07±0.7117.77±0.3518.97±0.1219.07±0.9818.90±0.32

MCHC17 (g/dL)34.23±0.0933.93±0.2333.50±0.5933.03±0.5233.70±0.2132.63±0.1533.40±0.45

RDW18 (% )13.07±0.7713.27±0.3512.67±0.2313.17±0.5212.67±0.2012.83±0.0712.50±0.36

PLT19 (K/μL)1010.67±54.051052.33±36.391096.00±65.821006.00±36.51768.67±330.741068.67±72.09991.00±130.50

MPV20 (fL)10.13±0.159.10±0.357.67±1.5210.23±0.3810.37±0.128.93±0.436.53±0.66

1, white blood cell; 2, neutrophils; 3, lymphocyte; 4, monocyte; 5, eosinophil; 6, basophil; 7, percent of neutrophils; 8, percent of lymphocyte; 9, percent of monocyte; 10, percent of eosinophil; 11, percent of basophil; 12, red blood cell; 13, hemoglobin; 14, hematocrit; 15, mean corpuscular volume; 16, mean corpuscular hemoglobin; 17, mean corpuscular hemoglobin concentration; 18, red cell distribution width; 19, platelet; 20, mean platelet volume. a: p<0.05, compared with G2, G3, and G4 group; b: p<0.01, compared with G1, G2, G4, G5, and G6 group.